402 related articles for article (PubMed ID: 27277133)
21. Desensitization regimens for drug allergy: state of the art in the 21st century.
Liu A; Fanning L; Chong H; Fernandez J; Sloane D; Sancho-Serra M; Castells M
Clin Exp Allergy; 2011 Dec; 41(12):1679-89. PubMed ID: 21883538
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal Antibodies Hypersensitivity: Prevalence and Management.
Santos RB; Galvão VR
Immunol Allergy Clin North Am; 2017 Nov; 37(4):695-711. PubMed ID: 28965635
[TBL] [Abstract][Full Text] [Related]
23. Management of Hypersensitivity Reactions to Taxanes.
Picard M
Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper.
Atanaskovic-Markovic M; Gomes E; Cernadas JR; du Toit G; Kidon M; Kuyucu S; Mori F; Ponvert C; Terreehorst I; Caubet JC
Pediatr Allergy Immunol; 2019 May; 30(3):269-276. PubMed ID: 30734362
[TBL] [Abstract][Full Text] [Related]
25. [Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy].
Sachs B; Merk HF
Hautarzt; 2018 Apr; 69(4):268-277. PubMed ID: 29520502
[TBL] [Abstract][Full Text] [Related]
26. Utilizing Biologics in Drug Desensitization.
Yang BC; Castells MC
Curr Allergy Asthma Rep; 2023 Jan; 23(1):1-11. PubMed ID: 36445652
[TBL] [Abstract][Full Text] [Related]
27. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
Sfikakis PP
Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
[TBL] [Abstract][Full Text] [Related]
28. Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.
Caiado J; Castells MC
Curr Allergy Asthma Rep; 2021 Jul; 21(6):37. PubMed ID: 34232411
[TBL] [Abstract][Full Text] [Related]
29. Hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies: Safety and efficacy of desensitization.
Villarreal-González RV; González-Díaz S; Vidal-Gutiérrez O; Cruz-de la Cruz C; Pérez-Ibave DC; Garza-Rodríguez ML
J Oncol Pharm Pract; 2023 Jul; ():10781552231189461. PubMed ID: 37489025
[TBL] [Abstract][Full Text] [Related]
30. Drug-induced Anaphylaxis.
Labella M; de Santa María RS; Bogas G; Salas M; Fernández TD; Mayorga C; Torres MJ; Doña I
Curr Pharm Des; 2023; 29(3):196-208. PubMed ID: 36284381
[TBL] [Abstract][Full Text] [Related]
31. Adalimumab in the treatment of immune-mediated diseases.
Lapadula G; Marchesoni A; Armuzzi A; Blandizzi C; Caporali R; Chimenti S; Cimaz R; Cimino L; Gionchetti P; Girolomoni G; Lionetti P; Marcellusi A; Mennini FS; Salvarani C
Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):33-48. PubMed ID: 24774505
[TBL] [Abstract][Full Text] [Related]
32. Hypersensitivity to monoclonal antibodies used for cancer and inflammatory or connective tissue diseases.
Hong D; Sloane DE
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):35-41. PubMed ID: 31028896
[TBL] [Abstract][Full Text] [Related]
33. Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations.
Castells M
Front Immunol; 2017; 8():1472. PubMed ID: 29163536
[TBL] [Abstract][Full Text] [Related]
34. Practical Management of Patients with a History of Immediate Hypersensitivity to Common non-Beta-Lactam Drugs.
Macy E
Curr Allergy Asthma Rep; 2016 Jan; 16(1):4. PubMed ID: 26714689
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy and biotherapy-induced hypersensitivity reactions.
Van Gerpen R
J Infus Nurs; 2009; 32(3):157-65. PubMed ID: 19444023
[TBL] [Abstract][Full Text] [Related]
36. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects.
Sicherer SH; Leung DY
J Allergy Clin Immunol; 2006 Jul; 118(1):170-7. PubMed ID: 16815152
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of anaphylaxis in precision medicine.
Castells M
J Allergy Clin Immunol; 2017 Aug; 140(2):321-333. PubMed ID: 28780940
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
Lee C; Gianos M; Klaustermeyer WB
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
[TBL] [Abstract][Full Text] [Related]
39. Management of hypersensitivity reactions: a nursing perspective.
Viale PH
Oncology (Williston Park); 2009 Feb; 23(2 Suppl 1):26-30. PubMed ID: 19385164
[TBL] [Abstract][Full Text] [Related]
40. Preventing and managing drug-induced anaphylaxis.
Drain KL; Volcheck GW
Drug Saf; 2001; 24(11):843-53. PubMed ID: 11665871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
